NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Proteon Pharmaceuticals

Proteon Pharmaceuticals

Private
PolandHealthcare & Life Scienceshttps://proteonpharma.com/

Last Round

Grant

Nov 9, 2022

Total Funding Raised

$33.91M

Company Overview

Proteon Pharmaceuticals is a biotechnology company that develops bacteriophage-based products to reduce the need for antibiotics in livestock farming and aquaculture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

bacteriophage technologyphage therapyanimal feed additivesantibiotic alternativesantimicrobial resistanceAMRagritechpoultry healthaquaculture healthanimal healthlivestock healthfood safetyanimal microbiomephage discovery platformSalmonella controlAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proteon Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Proteon Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Proteon Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 9, 2022
Series BAug 10, 2021
Series AOct 26, 2017
GrantFeb 6, 2017
GrantSep 1, 2016

Key People

Founding team and executive leadership

Jaroslaw Dastych

Founder And CEO

Founding Team

ACCA Mariana Krulikovska

Deputy Chief Financial Officer

Executive Team

Proteon Pharmaceuticals Investors

Notable investors and investment history

Proteon Pharmaceuticals investors
InvestorRounds
Newtree ImpactSeries B
Calouste Gulbenkian FoundationGrant
Bluebio AllianceGrant
PFR Life ScienceSeries B
Aqua-SparkSeries B, Series A
maze impactGrant
Oceano Azul FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2022

    $45K grant round led by Blue Bio Value.

Proteon Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Proteon Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Proteon Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersPoland
Employee Range49
Year Founded2005
Last FundingNov 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.